Essential for testing or discovering:
|
• Cause-and-effect relationships |
• New biological concepts |
• Preclinical safety and efficacy of candidate drugs |
• Biological significance of in vitro findings |
• Identification of novel potential virulence factors |
• Identification of novel potential therapeutic targets |
Limitations:
|
• Do not faithfully replicate all aspects of human disease |
• Need to confine their use to addressing hypotheses related to specific disease aspects |
• More than one model may be required to obtain adequate insight |
Contributions to the understanding and treatment of oral diseases:
|
• Etiologic role of bacteria and sucrose in dental caries |
• Etiologic role of bacteria and host response in periodontitis |
• Laying the foundation for mucosal immunization against pathogens that colonize or invade via mucosal surfaces |
• Dysbiosis rather than individual pathogens cause periodontitis |
• Mechanistic underpinnings substantiating the epidemiological association of periodontitis with inflammatory comorbidities |
• Genetic basis of host susceptibility/resistance to caries or periodontitis |
• Discovery that tetracyclines inhibit tissue breakdown independently of antimicrobial action: anticollagenolytic effects |
• Identification of IL-23 blockade for the treatment of human LAD1 periodontitis |
• Identification of complement C3 as therapeutic target in human periodontitis (phase 2a trial) |